{"id":"https://genegraph.clinicalgenome.org/r/1a2a2064-bebb-4c34-80e9-e84215cafa25v1.0","type":"EvidenceStrengthAssertion","dc:description":"CIITA was first reported in relation to autosomal recessive major histocompatibility complex (MHC) class II deficiency by (Steimle et al., PMID:8402893). MHC class II molecules are essential for the presentation of exogenous peptides to CD4+ helper T cells and thus in the adaptive immune response. Mutations in four trans-acting genes CIITA, RFXANK, RFX5, and RFXAP are responsible for the primary immunodeficiency. 21 total variants, including (nonsense, missense, and splice site) have been reported in 11 probands in 11 publications. Affected individuals typically present in infancy with severe, recurrent infections, failure to thrive, low levels of CD4+ T cells, and undetectable HLA-DR expression on monocytes and B cells. The mechanism of pathogenicity appears to be loss of function.\n\nThis gene-disease association is supported by experimental evidence including animal models (PMID: 8624807). Mice that are homozygous with loss of function CIITA alleles (-/-) display a lack of MHC class II molecules on B cells and macrophages and low levels of peripheral CD4+ cells. They are also unable to form a proliferative T-cell response following immunization. Further experimental evidence that supports a causative role of CIITA for this disorder includes co-immunoprecipitation (PMID: 10913187), rescue of function in patient and non-patient cells (PMIDs: 8402893, 25940550), expression (PMID:16818750) and biochemical function (PMID: 11332992).\n\nIn summary, CIITA is definitively associated with autosomal recessive MHC class II deficiency. This has been repeatedly demonstrated in both research and the clinical diagnostic setting and has been upheld over time. Heterozygous carriers of CIITA variants are not clinically reported to have the disease. Classification approved by SCID-CID GCEP on 10/20/2022 (SOP Version 9). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/1a2a2064-bebb-4c34-80e9-e84215cafa25","GCISnapshot":"https://genegraph.clinicalgenome.org/r/0dab225e-0bdd-4f96-a351-4e490601ba15","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/0dab225e-0bdd-4f96-a351-4e490601ba15_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10081","date":"2022-11-10T20:18:05.666Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/0dab225e-0bdd-4f96-a351-4e490601ba15_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10081","date":"2022-11-03T17:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0dab225e-0bdd-4f96-a351-4e490601ba15_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0dab225e-0bdd-4f96-a351-4e490601ba15_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee94fc5b-3e51-4d19-ac1c-ba3d51b1847f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c5b643e-b58d-42e1-8b12-ef67e79867cc","type":"Finding","dc:description":"CIITA knock out mice display a lack of MCH class 2 expression in B cells and macrophages and a decreased number of CD4 cells in the periphery, phenotypes that have been consistently reported in probands. Additionally, Knock out mice showed an impaired response to immunization, as indicated by an absence of T cell proliferation following KLH immunization. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8624807","rdfs:label":"Knock out CIITA mice ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5b53fd90-921a-406c-a454-ce87b7c45059","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b9ff339-0e36-42b6-aaa8-680764f37598","type":"Finding","dc:description":"Transduction of wild-type CIITA into CIITA null genes generated by CRISPR/CAS9 restored MHC class two expression. Additionally, transduction of wild type CIITA cDNA restored MHC class two mediated activation of alloreactive CD4+ memory T cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25940550","rdfs:label":"Abrahimi: CIITA rescue in primary human endothelial cells","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/18a18127-4e2a-4aec-aaaa-a4eb6a46d734","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec378941-67ba-4851-babd-3f08a46c300a","type":"Finding","dc:description":"B cell lines from three bare lymphocyte syndrome patients including BLS-2 were transfected with wild type CIITA. Patient BLS-2 was homozygous for a 72 base pair deletion that resulted in defective MHC class two expression. Transfection with WT CIITA resulted in complete expression of MHC class two receptors at wild type levels.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8402893","rdfs:label":"Steimle rescue in patient cells ","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/0dab225e-0bdd-4f96-a351-4e490601ba15_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff2e9bfc-a465-4c1a-80f8-fb1339cbfb90","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f6e7269d-22ab-4f19-a38e-30fc8ab069e8","type":"Finding","dc:description":"Deficiencies in CIITA have been consistently shown to result in a lack of MHC class two expression across multiple probands. This article demonstrates that transfection of CIITA increased MHC class two expression in dendritic cells. Additionally, the article demonstrates that CIITA increased the cytotoxicity of effector cells against tumor cells when effector cells were co-cultured with transfected dendritic cells. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11332992","rdfs:label":"Marten transfection of CIITA into Dendritic Cells","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f85396f9-07e4-47e3-9965-44dcf7c33b3e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e846f73-89b3-42b3-b80f-3d195752c7e6","type":"Finding","dc:description":"CIITA precipitated with NFY and RFX5 in both a cell free coimmunoprecipitation experiment and an in vivo coimmunoprecipitation. Like CIITA, mutations in RFX5 have also been identified in individuals with a phenotype consistent with MHC class two deficiency. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10913187","rdfs:label":"Zhu et al. CIITA in vitro and in vivo interactions","demonstrates":{"id":"obo:MI_0208"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fb09e470-ec3f-48aa-ae23-ef79e28edadc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96d3a0f2-9963-49d2-afb4-3f263e893dee","type":"Finding","dc:description":"CIITA protein was found to be expressed normally in human B cells and mouse B cells in western blotting. Additionally, the authors found that level of expression of CIITA in B cells is controlled by Protein Kinase C delta.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16818750","rdfs:label":"Kwon CIITA expression in B cells ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5},{"id":"https://genegraph.clinicalgenome.org/r/0dab225e-0bdd-4f96-a351-4e490601ba15_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c291e2b4-dfca-4a27-b10c-483ebd3cfc8f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7026bd0b-f784-4480-b3c8-1509d3332b7e","type":"EvidenceLine","dc:description":"Splice site mutation, pathogenic by ClinVar. Found in the East Asian population at a frequency of 0.0002005 (4/19946).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7026bd0b-f784-4480-b3c8-1509d3332b7e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Transfection experiments with CIITA cDNA from allele 2 of BCH confirmed that this second allele was not capable of producing a functional CIITA protein.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7026bd0b-f784-4480-b3c8-1509d3332b7e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9099848","allele":{"id":"https://genegraph.clinicalgenome.org/r/60dc9abc-7542-40de-81a7-2abaf9f71a4c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000246.4(CIITA):c.3317+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212922"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b8015365-aec9-4636-b55f-b5e0d422041f","type":"EvidenceLine","dc:description":"Not found in any population in GnomAD","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b8015365-aec9-4636-b55f-b5e0d422041f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The EBV-transformed B cell line BCH was transfected with wild-type CIITA cDNA.  Stably  transfected cells showed complete restoration of wild-type levels of ex-pression of surface HLA-DR, indicating the correction ofthe genetic defect of BCH by CIITA (Fig. 1a). RNase pro-tection analysis with a probe spanning the region deleted in BLS-2 indicated that CIITA was expressed in BCH at a level similar to that of a control B cell line.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b8015365-aec9-4636-b55f-b5e0d422041f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9099848","allele":{"id":"https://genegraph.clinicalgenome.org/r/6d4e05d7-9a46-4ee5-91cb-25c02a24dcf5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000246.4(CIITA):c.1141G>T (p.Glu381Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA120530"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c291e2b4-dfca-4a27-b10c-483ebd3cfc8f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9099848","rdfs:label":"BCH","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/6d4e05d7-9a46-4ee5-91cb-25c02a24dcf5"},{"id":"https://genegraph.clinicalgenome.org/r/60dc9abc-7542-40de-81a7-2abaf9f71a4c"}],"detectionMethod":"PCR genotyping of the CIITA gene","firstTestingMethod":"PCR","phenotypeFreeText":"Undetected HLA-DR expression on monocytes, B cells","phenotypes":["obo:HP_0001508","obo:HP_0002721","obo:HP_0002205","obo:HP_0004313","obo:HP_0004395"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b8015365-aec9-4636-b55f-b5e0d422041f_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/7026bd0b-f784-4480-b3c8-1509d3332b7e_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/001782ec-bd1b-4e8b-ab1c-4770e0c49135_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c2ced15-30cb-4062-9950-743dfcdcd88f","type":"EvidenceLine","dc:description":"Scored down due to homozygosity. ","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c2ced15-30cb-4062-9950-743dfcdcd88f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The mutated CIITA cDNA of ATU was cloned into the expression vector pREP4 (pREP4-CIITAm) and transfected into ATU fibroblasts and into fibroblasts of another CIITA deficient patient, JVH. None of the transfectants expressed MHC class II molecules at the cell surface, confirming that the CIITA protein from ATU, missing 28 aa, was not functional. Additionally, transfection of ATU fibroblasts with WT-CIITA resulted in the expression of HLA-DR, HLA-DP, and HLA-DQ at the cell surface even without IFN-g treatment.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6c2ced15-30cb-4062-9950-743dfcdcd88f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10663561","allele":{"id":"https://genegraph.clinicalgenome.org/r/10a0f4a5-4897-4c6e-a692-9149931ec078","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000246.4(CIITA):c.3265_3348del (p.Ala1089_Ter1116delextTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320421"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/001782ec-bd1b-4e8b-ab1c-4770e0c49135","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10663561","rdfs:label":"Peijnenburg patient ATU ","allele":{"id":"https://genegraph.clinicalgenome.org/r/10a0f4a5-4897-4c6e-a692-9149931ec078"},"detectionMethod":"PCR preformed on CIITA gene ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Lack of mRNA expression of HLA-, DRA-, and Ii-specific transcripts upon induction with IFN-g","phenotypes":"obo:HP_0002721","previousTesting":false,"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/6c2ced15-30cb-4062-9950-743dfcdcd88f_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/baf56632-7a5a-4c88-846b-c65a13053fb2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ea5be5a-9944-439d-aa57-cd0a00f17612","type":"EvidenceLine","dc:description":"The c.3223C>T (p.Arg1075Trp) variant was not found in any population in GnomAD 2.1.1","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ea5be5a-9944-439d-aa57-cd0a00f17612_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33386785","allele":{"id":"https://genegraph.clinicalgenome.org/r/746041d2-5884-4b87-933e-f451f7965aed","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000246.4(CIITA):c.3223C>T (p.Arg1075Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA277691307"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/942201e8-8f8b-4eb9-aacd-92482b443e61","type":"EvidenceLine","dc:description":"The CIITA c.1240del (p.Arg414GlufsTer2) variant was not found in any population in GnomAD 2.1.1","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/942201e8-8f8b-4eb9-aacd-92482b443e61_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33386785","allele":{"id":"https://genegraph.clinicalgenome.org/r/e3baa123-d1a0-46bd-a450-68ab129e0d3f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000246.4(CIITA):c.1240del (p.Arg414GlufsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320393"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/baf56632-7a5a-4c88-846b-c65a13053fb2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33386785","rdfs:label":"Zhang Patient","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":9,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/e3baa123-d1a0-46bd-a450-68ab129e0d3f"},{"id":"https://genegraph.clinicalgenome.org/r/746041d2-5884-4b87-933e-f451f7965aed"}],"detectionMethod":"Next generation sequencing used to identify the mutations. Sanger sequencing was used to confirm the variants. Parental genotyping confirmed mutations were in trans.","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Increased CD8-positive T cell count.","phenotypes":["obo:HP_0012735","obo:HP_0002878","obo:HP_0004315","obo:HP_0002090","obo:HP_0001508","obo:HP_0001635","obo:HP_0004385","obo:HP_0000778","obo:HP_0004325","obo:HP_0033677","obo:HP_0004395","obo:HP_0100539","obo:HP_0002720","obo:HP_0033222","obo:HP_0008070","obo:HP_0003496","obo:HP_0000988","obo:HP_0006538","obo:HP_0032247","obo:HP_0031393","obo:HP_0005280"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8ea5be5a-9944-439d-aa57-cd0a00f17612_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/942201e8-8f8b-4eb9-aacd-92482b443e61_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/c7e6fff9-5162-4cb2-9fff-eda9106389ce_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd7060fe-430a-4165-a8c0-cfd0cf21d955","type":"EvidenceLine","dc:description":"Variant is absent from GnomAD in any population.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd7060fe-430a-4165-a8c0-cfd0cf21d955_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33386785","allele":{"id":"https://genegraph.clinicalgenome.org/r/f7cf7652-04fc-4cca-8c45-be7768c87aab","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000016.10:g.10906653G>A (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394729900"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c7e6fff9-5162-4cb2-9fff-eda9106389ce","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33386785","rdfs:label":"Chen et al P2","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f7cf7652-04fc-4cca-8c45-be7768c87aab"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"phenotypes":["obo:HP_0000988","obo:HP_0031393","obo:HP_0100806","obo:HP_0031394","obo:HP_0032218","obo:HP_0045080","obo:HP_0004315"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cd7060fe-430a-4165-a8c0-cfd0cf21d955_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8bb0c86a-4a57-4223-a025-e745ba63f351_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88722231-0aa3-4fe4-a61d-313c61d420ea","type":"EvidenceLine","dc:description":"Novel homozygous CIITA c.2436C>A (p.Cys812Ter) variant found in GnomAD at a minor allele frequency of 0.00006487 (1/15416) within the European Non-Finnish population. Downgraded due to homozygosity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88722231-0aa3-4fe4-a61d-313c61d420ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29527204","allele":{"id":"https://genegraph.clinicalgenome.org/r/953b3418-8f6c-4be2-b199-72528324ee69","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000246.4(CIITA):c.2436C>A (p.Cys812Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394733613"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8bb0c86a-4a57-4223-a025-e745ba63f351","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29527204","rdfs:label":"Aluri P4","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/953b3418-8f6c-4be2-b199-72528324ee69"},"detectionMethod":"Next generation sequencing preformed on the genes implicated in causing MHC class II-deficiency  (CIITA, RFXANK, RFX5, or RFXAP). Identified variants were confirmed by Sanger Sequencing. ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"No HLA-DR expression on B cells and monocytes. ","phenotypes":["obo:HP_0004315","obo:HP_0002850","obo:HP_0033677","obo:HP_0001508","obo:HP_0032260","obo:HP_0002720","obo:HP_0010975","obo:HP_0031394","obo:HP_0005407"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/88722231-0aa3-4fe4-a61d-313c61d420ea_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/351b3d06-1051-492e-84f8-b006e30e78d4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42a16195-0306-47d0-b377-edd66d32ee36","type":"EvidenceLine","dc:description":"Variant absent from GnomAD in all populations. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42a16195-0306-47d0-b377-edd66d32ee36_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Transfection of a CIITA-deficient cell line with the recombinant mutant cDNA revealed a loss of function for this mutant and retention of the protein in the cytoplasm.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/42a16195-0306-47d0-b377-edd66d32ee36_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11862382","allele":{"id":"https://genegraph.clinicalgenome.org/r/1256bf0d-ea71-450b-b884-14c54b77b3f8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000246.4(CIITA):c.3080_3082del (p.Ile1027del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320407"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/552c94df-c54b-4604-9759-0dd0f5cb43be","type":"EvidenceLine","dc:description":"Variant absent from GnomAD in all populations.  ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/552c94df-c54b-4604-9759-0dd0f5cb43be_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"NA","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/552c94df-c54b-4604-9759-0dd0f5cb43be_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11862382","allele":{"id":"https://genegraph.clinicalgenome.org/r/cbcd5252-21d2-4014-9600-b9f482d695cf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000016.10:g.10916403_10918463del (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320408"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/351b3d06-1051-492e-84f8-b006e30e78d4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11862382","rdfs:label":"Dziembowska RC","allele":[{"id":"https://genegraph.clinicalgenome.org/r/cbcd5252-21d2-4014-9600-b9f482d695cf"},{"id":"https://genegraph.clinicalgenome.org/r/1256bf0d-ea71-450b-b884-14c54b77b3f8"}],"detectionMethod":"PCR sequencing of CIITA of coding and noncoding regions.","firstTestingMethod":"PCR","phenotypeFreeText":"In fluorescence activated cell sorting (FACS) analysis peripheral B cells, monocytes, activated T lymphocytes, and IFN-Î³-induced fibroblasts were MHC II deficient.","phenotypes":["obo:HP_0031404","obo:HP_0031692","obo:HP_0004315","obo:HP_0002850","obo:HP_0003460","obo:HP_0032218"],"previousTesting":false,"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/552c94df-c54b-4604-9759-0dd0f5cb43be_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/42a16195-0306-47d0-b377-edd66d32ee36_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/0613b8c8-656b-4bc8-89db-f521b721b6bc_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/405fb109-5ebc-413d-838e-a117fbb927da","type":"EvidenceLine","dc:description":"Variant is absent from GnomAD in any population ","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/405fb109-5ebc-413d-838e-a117fbb927da_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26915675","allele":{"id":"https://genegraph.clinicalgenome.org/r/9863a691-8217-41a7-9e2b-fde42e7623c2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000246.4(CIITA):c.3136C>G (p.Leu1046Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394722843"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/0613b8c8-656b-4bc8-89db-f521b721b6bc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26915675","rdfs:label":"P1294","ageType":"AgeAtReport","ageUnit":"Months","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/9863a691-8217-41a7-9e2b-fde42e7623c2"},"detectionMethod":"Variant first detected by targeted next generation sequencing. Variant confirmed by Sanger Sequencing. ","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Total MHC class II <1%","phenotypes":["obo:HP_0032118","obo:HP_0001508","obo:HP_0032247","obo:HP_0002028"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/405fb109-5ebc-413d-838e-a117fbb927da_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/56205297-ec15-446e-82a0-870b7885df85_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a2387d4-55d7-49a6-9577-caa7c52efa0b","type":"EvidenceLine","dc:description":"Variant not found in any population in GnomAD v2.1.1. Downgraded score due to confirmed consanguinity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a2387d4-55d7-49a6-9577-caa7c52efa0b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26271388","allele":{"id":"https://genegraph.clinicalgenome.org/r/c97307cf-d71c-419d-b17c-66fa810ff0b8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000246.4(CIITA):c.682C>T (p.Gln228Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394728624"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/56205297-ec15-446e-82a0-870b7885df85","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26271388","rdfs:label":"Ahmed Patient ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c97307cf-d71c-419d-b17c-66fa810ff0b8"},"detectionMethod":"Sanger sequencing revealed the CIITA homozygous c.682 C>T nonsense mutation pGlu228X.","ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Peripheral blood flow cytometry revealed monocytes that were completely negative for HLA-DR. Absent lymphocyte proliferation to tetanus and candida. ","phenotypes":["obo:HP_0020102","obo:HP_0001508","obo:HP_0033222","obo:HP_0001882","obo:HP_0001875","obo:HP_0006528","obo:HP_0002720","obo:HP_0004315","obo:HP_0040219","obo:HP_0030388","obo:HP_0001947","obo:HP_0002719","obo:HP_0032218","obo:HP_0030381"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2a2387d4-55d7-49a6-9577-caa7c52efa0b_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ed36717f-96cc-4878-89e8-e64ed2c5fdba_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c901a243-5b3d-4da1-a11b-cfda41c1aa52","type":"EvidenceLine","dc:description":"Mutation absent from any population in GnomAD. Downgraded score due to consanguinity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c901a243-5b3d-4da1-a11b-cfda41c1aa52_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30170160","allele":{"id":"https://genegraph.clinicalgenome.org/r/c83350a6-6f3d-4033-a0ba-f3876107fc63","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000246.4(CIITA):c.929del (p.Asn310ThrfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320396"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ed36717f-96cc-4878-89e8-e64ed2c5fdba","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30170160","rdfs:label":"El Hawary Patient 8 ","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c83350a6-6f3d-4033-a0ba-f3876107fc63"},"detectionMethod":"Whole Exome Sequencing used to identify mutations. Mutations were then confirmed by Sanger Sequencing. ","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001508","obo:HP_0001522","obo:HP_0004315","obo:HP_0002090","obo:HP_0032218","obo:HP_0004385","obo:HP_0009098","obo:HP_0045080"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c901a243-5b3d-4da1-a11b-cfda41c1aa52_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/37ebe560-c7b7-4d82-b5a1-153be4d89be5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b9997457-d3d8-4e9d-96c4-8ee9135af1fd","type":"EvidenceLine","dc:description":"Scored down due to homozygosity. ","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b9997457-d3d8-4e9d-96c4-8ee9135af1fd_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"HeLa cells were transfected with either wild-type (pEBO-CIITA) or mutant (pEBO-CIITAF961S) CIITA and monitored for induction of class II gene expression. Cells transfected with pEBO-CIITAF961S remained class II negative in contrast to the expression of class II in WT cells. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b9997457-d3d8-4e9d-96c4-8ee9135af1fd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10501838","allele":{"id":"https://genegraph.clinicalgenome.org/r/15ff2208-d6e0-4b6f-bf40-9baf7f2fb527","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000246.4(CIITA):c.2885T>C (p.Phe962Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394735727"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/37ebe560-c7b7-4d82-b5a1-153be4d89be5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10501838","rdfs:label":"Quan Patient","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":30,"allele":{"id":"https://genegraph.clinicalgenome.org/r/15ff2208-d6e0-4b6f-bf40-9baf7f2fb527"},"detectionMethod":"PCR sequencing of the CIITA gene","firstTestingMethod":"PCR","phenotypeFreeText":"Reduction in CIITA expression observed in the patient","phenotypes":["obo:HP_0002718","obo:HP_0002721","obo:HP_0100613"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b9997457-d3d8-4e9d-96c4-8ee9135af1fd_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e32c218e-bda2-4174-a22e-e0aa5c11b1cf_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6acf218d-8140-4d2c-9b33-df55f6e733d9","type":"EvidenceLine","dc:description":"Splice site mutation, variant pathogenic by ClinVar. Found to be complete loss of function by Bontron et al., PMID: 9099848. Found in East Asian population in GnomAD at a rate of 0.0002005 (4/19946).\t ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6acf218d-8140-4d2c-9b33-df55f6e733d9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24789686","allele":{"id":"https://genegraph.clinicalgenome.org/r/60dc9abc-7542-40de-81a7-2abaf9f71a4c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e32c218e-bda2-4174-a22e-e0aa5c11b1cf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24789686","rdfs:label":"Dimitrova patient ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/60dc9abc-7542-40de-81a7-2abaf9f71a4c"},"detectionMethod":"Unspecified sequencing method of CIITA, WAS, Jak3, IL2Rg, IKBKG (NEMO), IFNgR1/2, RAG1/2, DCLRE1C (ARTEMIS), IL7R, CD3D, CD3E and GATA2, which detected no pathogenic variants. Microarray used to identify a 300 kb copy number gain at Xq28, involving the genes F8, FUNDC2, MTCP1NB, MTCP1, BRCC3, but no significant areas of non-heterozygosity","ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"Chromosomal microarray","phenotypeFreeText":"Flow cytometry demonstrated absent HLA-DR antigen expression on monocytes and B-cells, consistent with MHCII deficiency","phenotypes":["obo:HP_0005403","obo:HP_0002721","obo:HP_0011342","obo:HP_0100806","obo:HP_0000316","obo:HP_0033399","obo:HP_0001875","obo:HP_0008070","obo:HP_0002090","obo:HP_0011109","obo:HP_0031417","obo:HP_0004313","obo:HP_0410303","obo:HP_0040219","obo:HP_0001508","obo:HP_0000403","obo:HP_0009098","obo:HP_0410295"],"previousTesting":false,"secondTestingMethod":"Other","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6acf218d-8140-4d2c-9b33-df55f6e733d9_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":5335,"specifiedBy":"GeneValidityCriteria9","strengthScore":17.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/QG3SJJfVhrc","type":"GeneValidityProposition","disease":"obo:MONDO_0008855","gene":"hgnc:7067","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_0dab225e-0bdd-4f96-a351-4e490601ba15-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}